SCHEMBL29566998

SCHEMBL29566998

C[C@H](NC(=O)CN)C(=O)N[C@@H](C)C(=O)NCC(=O)O

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 1/20 0.47
▸ LMNA P02545 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ PTGS2 P35354 1/20 0.47
▸ TDP1 Q9NUW8 1/20 0.47
▸ ECE1 P42892 1/20 0.42
▸ MME P08473 2/20 0.41
▸ ACE P12821 2/20 0.41
▸ CPA1 P15085 1/20 0.41
▸ ACE2 Q9BYF1 1/20 0.41
▸ CTSC P53634 1/20 0.37
▸ PTGS1 P23219 1/20 0.36
▸ GSTK1 Q9Y2Q3 1/20 0.36
▸ OPRD1 P41143 5/20 0.36
▸ OPRM1 P35372 4/20 0.36
▸ OPRK1 P41145 1/20 0.36
▸ GLO1 Q04760 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11656504 0.96 ALDH1A1 (0.50) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL11656501 0.96 ALDH1A1 (0.50) ALDH1A1LMNAMAPTPTGS2TDP1
Hydrochloric Acid SCHEMBL29398511 0.95 ALDH1A1 (0.48) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL16777806 0.93 ALDH1A1 (0.47) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL29630333 0.92 ALDH1A1 (0.46) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL29906337 0.90 ALDH1A1 (0.39) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL11657859 0.88 ALDH1A1 (0.46) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL11657849 0.88 ALDH1A1 (0.46) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL30569806 0.87 ALDH1A1 (0.42) ALDH1A1LMNAMAPTPTGS2TDP1
SCHEMBL11657554 0.87 ALDH1A1 (0.44) ALDH1A1LMNAMAPTPTGS2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3632458-B1 METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF BACTERIAL INFECTIONS INST NAT SANTE RECH MED (FR) 2025-03-19 — — EP claimed
CN-118871092-A Aerosol composition for pulmonary delivery of flagellin INSERM(法国国家健康医学研究院) 2024-10-29 — — CN disclosed
US-20230372416-A1 COMBINATION OF INHALED ANTIBODIES AND IMMUNOMODULATORY AGENTS FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS UNIVERSITÉ DE TOURS (FR) 2023-11-23 — — US disclosed
EP-4225341-A1 COMBINATION OF INHALED ANTIBODIES AND IMMUNOMODULATORY AGENTS FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS Université de Tours (FR) 2023-08-16 — — EP disclosed
WO-2022074348-A1 COMBINATION OF INHALED ANTIBODIES AND IMMUNOMODULATORY AGENTS FOR THE TREATMENT OR PREVENTION OF RESPIRATORY INFECTIONS UNIVERSITÉ DE TOURS (FR) 2022-04-14 — — WO disclosed
Send feedback